Letter from the editor: Avoiding delays in emergent treatment of generalized pustular psoriasis
- 13 October 2023
- journal article
- editorial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 90 (4) , 705-706
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Genetics of Generalized Pustular Psoriasis: Current Understanding and Implications for Future TherapeuticsGenes, 2023
- Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre‐specified patient subgroups in the Effisayil 1 studyExperimental Dermatology, 2023
- Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trialBritish Journal of Dermatology, 2023
- Management of adult generalized pustular psoriasis using biologics: A systematic reviewJournal of the American Academy of Dermatology, 2023
- Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 studyJournal of the American Academy of Dermatology, 2023
- Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis FlaresDermatology, 2023